Janus Henderson Group PLC Ptc Therapeutics, Inc. Call Options Transaction History
Janus Henderson Group PLC
- $174 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PTCT
# of Institutions
283Shares Held
78.5MCall Options Held
223KPut Options Held
156K-
Vanguard Group Inc Valley Forge, PA8.61MShares$404 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$365 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.48MShares$351 Million6.25% of portfolio
-
Armistice Capital, LLC New York, NY5.43MShares$255 Million4.22% of portfolio
-
Wellington Management Group LLP Boston, MA5.42MShares$254 Million0.05% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.36B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...